Association of blood monocyte and platelet markers with carotid artery characteristics: The atherosclerosis risk in communities carotid MRI study

Cerebrovascular Diseases

Volumn 31, Issue 6, 2011, Pages 552-558

  Matijevic, N ^a   Wu, K K ^f   Howard, A G ^b   Wasserman, B ^c   Wang, W Y W ^a   Folsom, A R ^d   Sharrett, A R ^e  

^a UNIVERSITY OF TEXAS   (United States)

^b The University of North Carolina at Chapel Hill   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Atherosclerosis; Flow cytometry; Magnetic resonance imaging

Indexed keywords

CD14 ANTIGEN; CD40 LIGAND; MYELOPEROXIDASE; PADGEM PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ADULT; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL WALL; CAROTID ARTERY; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; MONOCYTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOCYTE;

AGED; BIOLOGICAL MARKERS; BLOOD PLATELETS; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MONOCYTES; PREVALENCE; PROSPECTIVE STUDIES; RESIDENCE CHARACTERISTICS; RISK FACTORS;

EID: 79953767177     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000324389     Document Type: Article

References (37)

1. Ross R: Atherosclerosis -an inflammatory disease. N Engl J Med 1999; 340: 115-126.
2. Libby P: Inflammation in atherosclerosis. Nature 2002; 420: 868-874. (Pubitemid 36019640)
3. Linton MF, Fazio S: Macrophages, inflammation, and atherosclerosis. Int J Obes Relat Metab Disord 2003; 27(suppl 3):S35-S40. (Pubitemid 38019186)
4. Gerrity RG: The role of the monocyte in atherogenesis. I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol 1981; 103: 181-190. (Pubitemid 11112973)
5. The ARIC Investigators: The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 1989; 129: 687-702.
6. Folsom AR, Aleksic N, Sanhueza A, Boerwinkle E: Risk factor correlates of platelet and leukocyte markers assessed by flow cytometry in a population-based sample. Atherosclerosis 2009; 205: 272-278.
7. Wasserman BA, Smith WI, Trout HH, Cannon RO, Balaban RS, Arai AE: Carotid artery atherosclerosis: in vivo morphologic characterization with gadolinium-enhanced double-oblique MR imaging: initial results. Radiology 2002; 223: 566-573. (Pubitemid 34454344)
8. Wagenknecht L, Wasserman B, Chambless L, Coresh J, Folsom A, Mosley T, Ballantyne C, Sharrett R, Boerwinkle E: Correlates of carotid plaque presence and composition as measured by MRI: the Atherosclerosis Risk in Communities Study. Circ Cardiovasc Imaging 2009; 2: 314-322.
9. Warrino DE, DeGennaro LJ, Hanson M, Swindells S, Pirruccello SJ, Ryan WL: Stabilization of white blood cells and immunologic markers for extended analysis using flow cytometry. J Immunol Methods 2005; 305: 107-119. (Pubitemid 41416706)
10. Catellier DJ, Aleksic N, Folsom AR, Boerwinkle E: Atherosclerosis Risk in Communities (ARIC) Carotid MRI flow cytometry study of monocyte and platelet markers: intraindividual variability and reliability. Clin Chem 2008; 54: 8.
11. Tobias PS, Curtiss LK: Toll-like receptors in atherosclerosis. Biochem Soc Trans 2007; 35: 1453-1455.
12. Mullick AE, Tobias PS, Curtiss LK: Modulation of atherosclerosis in mice by Toll-like receptor 2. J Clin Invest 2005; 115: 3149-3156. (Pubitemid 41567579)
13. Schoneveld AH, Hoefer I, Sluijter JP, Laman JD, de Kleijn DP, Pasterkamp G: Atherosclerotic lesion development and Toll like receptor 2 and 4 responsiveness. Atherosclerosis 2008; 197: 95-104. (Pubitemid 351273277)
14. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F: Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 1999; 274: 10689-10692.
15. Lien E, Means TK, Heine H, Yoshimura A, Kusumoto S, Fukase K, Fenton MJ, Oikawa M, Qureshi N, Monks B, Finberg RW, Ingalls RR, Golenbock DT: Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest 2000; 105: 497-504. (Pubitemid 30127250)
16. Pasterkamp G, Van Keulen JK, De Kleijn DP: Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease. Eur J Clin Invest 2004; 34: 328-334. Review. (Pubitemid 38748072)
17. Ashida K, Miyazaki K, Takayama E Tsujimoto H, Ayaori M, Yakushiji T, Iwamoto N, Yonemura A, Isoda K, Mochizuki H, Hiraide H, Kusuhara M, Ohsuzu F: Characterization of the expression of TLR2 (toll-like receptor 2) and TLR4 on circulating monocytes in coronary artery disease. J Atheroscler Thromb 2005; 12: 53-60.
18. Satoh M, Shimoda Y, Maesawa C, Akatsu T, Ishikawa Y, Minami Y, Hiramori K, Nakamura M: Activated toll-like receptor 4 in monocytes is associated with heart failure after acute myocardial infarction. Int J Cardiol 2006; 109: 226-234.
19. Devaraj S, Dasu MR, Rockwood J, Winter W, Griffen SC, Jialal I: Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Metab 2008; 93: 578-583. (Pubitemid 351240834)
20. Parsons SA, Greer PA: The Fps/Fes kinase regulates the inflammatory response to endotoxin through down-regulation of TLR4, NF-kappaB activation, and TNF-alpha secretion in macrophages. J Leukoc Biol 2006; 80: 1522-1528. (Pubitemid 44904991)
21. Luu NT, Madden J, Calder PC Grimble RF, Shearman CP, Chan T, Tull SP, Dastur N, Rainger GE, Nash GB: Comparison of the pro-inflammatory potential of monocytes from healthy adults and those with peripheral arterial disease using an in vitro culture model. Atherosclerosis 2007; 193: 259-268. (Pubitemid 47058114)
22. Baldus S, Heeschen C, Meinertz T, Zeiher AM, Eiserich JP, Münzel T, Simoons ML, Hamm CW; CAPTURE Investigators: myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 2003; 108: 1440-1445. (Pubitemid 37176448)
23. Brennan ML, Hazen SL: Emerging role of myeloperoxidase and oxidant stress markers in cardiovascular risk assessment. Curr Opin Lipidol 2003; 14: 353-359. Review. (Pubitemid 36951900)
24. Kutter D, Devaquet P, Vanderstocken G, Paulus JM, Marchal V, Gothot A: Consequences of total and subtotal myeloperoxidase deficiency: risk or benefit? Acta Haematol 2000; 104: 10-15.
25. Nikpoor B, Turecki G, Fournier C, Théroux P, Rouleau GA: A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians. Am Heart J 2001; 142: 336-339. (Pubitemid 32706293)
26. Brevetti G, Schiano V, Laurenzano E, Giugliano G, Petretta M, Scopacasa F, Chiariello M: Myeloperoxidase, but not C-reactive protein, predicts cardiovascular risk in peripheral arterial disease. Eur Heart J 2008; 29: 224-230. (Pubitemid 351164877)
27. Monaco C, Rossi E, Milazzo D, Citterio F, Ginnetti F, D'Onofrio G, Cianflone D, Crea F, Biasucci LM, Maseri A: Persistent systemic inflammation in unstable angina is largely unrelated to the atherothrombotic burden. J Am Coll Cardiol 2005; 45: 238-243. (Pubitemid 40094731)
28. Burger PC, Wagner DD: Platelet P-selectin facilitates atherosclerotic lesion development. Blood 2003; 101: 2661-2666. (Pubitemid 36857627)
29. Rinder HM, Bonan JL, Rinder CS, Ault KA, Smith BR: Dynamics of leukocyte-platelet adhesion in whole blood. Blood 1991; 78: 1730-1737.
30. Yokoyama S, Ikeda H, Haramaki N, Yasukawa H, Murohara T, Imaizumi T: Platelet P-selectin plays an important role in arterial thrombogenesis by forming large stable platelet-leukocyte aggregates. J Am Coll Cardiol 2005; 45: 1280-1286. (Pubitemid 40523150)
31. McEver RP: Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation. Thromb Haemost 2001; 86: 746-756. (Pubitemid 32834182)
32. Huo Y, Schober A, Forlow SB, Smith DF, Hyman MC, Jung S, Littman DR, Weber C, Ley K: Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 2003; 9: 61-67. (Pubitemid 36098261)
33. Koyama H, Maeno T, Fukumoto S, Shoji T, Yamane T, Yokoyama H, Emoto M, Shoji T, Tahara H, Inaba M, Hino M, Shioi A, Miki T, Nishizawa Y: Platelet P-selectin expression is associated with atherosclerotic wall thickness in carotid artery in humans. Circulation 2003; 108: 524-529. (Pubitemid 36961164)
34. Fateh-Moghadam S, Li Z, Ersel S, Reuter T, Htun P, Plöckinger U, Bocksch W, Dietz R, Gawaz M: Platelet degranulation is associated with progression of intima-media thickness of the common carotid artery in patients with diabetes mellitus type 2. Arterioscler Thromb Vasc Biol 2005; 25: 1299-1303. (Pubitemid 40776625)
35. Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI: Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 2001; 104: 1533-1537. (Pubitemid 32917347)
36. May AE, Langer H, Seizer P, Bigalke B, Lindemann S, Gawaz M: Platelet-leukocyte interactions in inflammation and atherothrombosis. Semin Thromb Hemost 2007; 33: 123-127. (Pubitemid 46427753)
37. McCabe DJ, Harrison P, Mackie IJ, Sidhu PS, Purdy G, Lawrie AS, Watt H, Machin SJ, Brown MM: Increased platelet count and leucocyte-platelet complex formation in acute symptomatic compared with asymptomatic severe carotid stenosis. J Neurol Neurosurg Psychiatry 2005; 76: 1249-1254. (Pubitemid 41208378)